ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Refeeding syndrome in head and neck cancers: a risk in the prehabilitation of patients?
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Refeeding syndrome (RS) is characterized by electrolyte and fluid shifts caused by the rapid reintroduction of nutrition after a period of undernutrition. This study aimed to determine the prevalence of RS in patients with head and neck cancer (HNC) affected by a malnutrition risk. The study involved 69 patients with HNC at the outset of management with one of the following risk factors of RS: BMI ≤ 18.5 kg/m2, weight loss > 5%, significant decrease in oral intake on a visual analog scale (≤ 5), or inability to swallow. RS was defined by serum ionic depletion (phosphorus, potassium, magnesium) within 5 days of refeeding. The study sample comprised 51 males and 18 females with a mean age of 62.80 ± 9.19 SD. Oropharyngeal squamous cell carcinoma (SCC) was the most prevalent histologic type in these patients (42%), predominantly associated with a negative P16 status and a high prevalence of a current or past history of smoking (94.2%) and/or alcoholism (69.6%). RS prevalence was 98% in the patients who had risk factors of malnutrition. No patient had organ failure. No clinical criteria were able to predict the severity of RS. RS is extremely common in malnourished patients with HNC. With adequate supplementation and close laboratory monitoring of refeeding, RS rarely causes clinical complications. The very high prevalence of RS in this study is due to the inclusion of patients with risk factors for malnutrition, this indicates that these factors are highly predictive of RS in patients with HNC.
Indexed as
Identifiers
40483353What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.